Telescope Innovations Corp. (TELI.CN)

CAD 0.35

(6.15%)

EBITDA Summary of Telescope Innovations Corp.

  • Telescope Innovations Corp.'s latest annual EBITDA in 2022 was -5.49 Million CAD , down -36.51% from previous year.
  • Telescope Innovations Corp.'s latest quarterly EBITDA in 2023 Q3 was 165.98 Thousand CAD , up 94.05% from previous quarter.
  • Telescope Innovations Corp. reported an annual EBITDA of -4.02 Million CAD in 2021, down -2771.62% from previous year.
  • Telescope Innovations Corp. reported an annual EBITDA of -140.05 Thousand CAD in 2020, down 0.0% from previous year.
  • Telescope Innovations Corp. reported a quarterly EBITDA of 85.53 Thousand CAD for 2023 Q2, up 137.52% from previous quarter.
  • Telescope Innovations Corp. reported a quarterly EBITDA of -227.96 Thousand CAD for 2023 Q1, up 66.44% from previous quarter.

Annual EBITDA Chart of Telescope Innovations Corp. (2022 - 2020)

Historical Annual EBITDA of Telescope Innovations Corp. (2022 - 2020)

Year EBITDA EBITDA Growth
2022 -5.49 Million CAD -36.51%
2021 -4.02 Million CAD -2771.62%
2020 -140.05 Thousand CAD 0.0%

Peer EBITDA Comparison of Telescope Innovations Corp.

Name EBITDA EBITDA Difference
Algernon Pharmaceuticals Inc. -4.98 Million CAD -10.217%
Asep Medical Holdings Inc -8.13 Million CAD 32.517%
BetterLife Pharma Inc. -3.19 Million CAD -72.035%
BioVaxys Technology Corp. -7.68 Million CAD 28.578%
ChitogenX Inc. -2.69 Million CAD -103.802%
Rapid Dose Therapeutics Corp. -3.02 Million CAD -81.518%
Defence Therapeutics Inc. -12.67 Million CAD 56.686%
Entheon Biomedical Corp. 13.99 Thousand CAD 39336.997%
Gemina Laboratories Ltd. -5.17 Million CAD -6.079%
Glow Lifetech Corp. -1.26 Million CAD -334.7%
Lexston Life Sciences Corp. -648.32 Thousand CAD -746.866%
Pharmala Biotech Holdings Inc. -710.18 Thousand CAD -673.099%
Doseology Sciences Inc. -319.47 Thousand CAD -1618.564%
MYND Life Sciences Inc. -1.82 Million CAD -200.813%
Nova Mentis Life Science Corp. -1.2 Million CAD -356.661%
PharmaTher Holdings Ltd. -3.04 Million CAD -80.406%
PreveCeutical Medical Inc. -955.08 Thousand CAD -474.861%